Summary:
Medical researchers are now evaluating an investigational drug taken once every four weeks for relapsing remitting multiple sclerosis.
Qualified Participants Must:
• Be 18-64 years of age
•
Have been diagnosed with RRMS
•
Have had one relapse episode in the last 12 months
Qualified Participants May Receive:
Study related medication in addition to study related comprehensive medical and laboratory evaluations at no cost.